Remove Biotech Remove Innovation Remove Marketing
article thumbnail

In an increasingly hot biotech market, protecting IP is key

TechCrunch

John Flavin is founder and CEO of Portal Innovations, LLC. 2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 billion invested across 1,073 deals — the market for new innovations remains strong.

Biotech 240
article thumbnail

IPO Readiness: What Biotech Startups And Others Need To Know

Crunchbase News

Given this success, many biotech companies are looking to move on to the next phase of their organizational growth — which may mean an initial public offering. As optimism grows, market conditions may stabilize in 2025 — particularly in the wake of the recent interest rate cuts — and more biotech companies may consider offerings.

Biotech 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

Deep tech disruption: How advanced technologies are transforming businesses

CIO

CEOs, CIOs and CFOs are finding that deep tech is actively driving business innovation and profitability. From lab to market at lightning speed Not long ago, cutting-edge research might take decades to translate into real-world products. The path from lab to market keeps shortening.

article thumbnail

This VC built a lab to make building biotech startups easier

TechCrunch

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. where do you travel to in your mind? The Bay Area?

Biotech 203
article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. One of the primary obstacles is the need for more highly skilled and qualified talent.

Biotech 178
article thumbnail

The Case For Revenue-Focused Platforms In The Life Sciences

Crunchbase News

By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Does the market see value in the tool today, or do you need to educate? What is your superpower?

Biotech 115